{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T04:12:49Z","timestamp":1749010369008,"version":"3.41.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Intravenous high-dose methotrexate (MTX \u2265 1 g\/m<jats:sup>2<\/jats:sup>) is frequently used in patients with cerebral lymphoma or other malignancies. In addition to its potent efficacy, it is known to have pronounced toxicity and life-threatening side effects. Regular-level monitoring at short and defined intervals is mandatory. This study aimed to evaluate the possibility of replacing peripheral blood sampling with blood samples from central venous catheters for therapeutic monitoring of MTX in adults.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A total of 6 patients and 7 cycles of chemotherapy (6 females; 5 with cerebral non-Hodgkin lymphoma and 1 with osteosarcoma, median age 51 years; range 33\u201362 years) were included. An immunoassay was used for quantitative analysis of MTX levels. The measurement points were obtained in the time intervals of 24, 42, 48, and 72 hours, and afterward, every 24 hours until the level was below &lt;0.1 \u00b5mol\/L. After flushing with 10 mL of saline solution and discarding 10 mL of venous blood, blood was drawn from the central venous access through which MTX had previously been administered. Simultaneously, MTX levels were obtained from peripheral venipuncture.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Methotrexate levels from central venous access and MTX levels from peripheral venipuncture showed a significant correlation (r = 0.998; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.01; n = 35). During withdrawal from the central access group, 17 values showed a lower MTX level, 10 showed a higher level, and 8 showed no difference. However, the MTX level difference was not significant (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.997, linear mixed model). No increase in the dose of calcium folinate was necessary based on the collected MTX levels.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In adults, MTX monitoring from central venous access is not inferior to monitoring from peripheral venipuncture. Repeated venipuncture to measure MTX levels can be replaced after establishing standardized instructions for proper sampling by a central venous catheter.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001080","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T22:00:05Z","timestamp":1677794405000},"page":"364-367","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Methotrexate Drug Monitoring From Central Access: Can Blood Sample Collection From Central Venous Access Replace Peripheral Venipuncture in Adults?"],"prefix":"10.1097","volume":"45","author":[{"given":"Enver","family":"Aydilek","sequence":"first","affiliation":[{"name":"Hematology and Medical Oncology and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Schanz","sequence":"additional","affiliation":[{"name":"Hematology and Medical Oncology and"},{"name":"Laboratory Medicine (UMG-Laboratory) and Clinical Chemistry, University Medicine G\u00f6ttingen, G\u00f6ttingen, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils","family":"Br\u00f6kers","sequence":"additional","affiliation":[{"name":"Hematology and Medical Oncology and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,2,28]]},"reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1200\/JCO.2017.72.7602","article-title":"Primary CNS lymphoma","volume":"35","author":"Grommes","year":"2017","journal-title":"J Clin Oncol."},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1182\/asheducation-2017.1.565","article-title":"Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents","volume":"2017","author":"Ferreri","year":"2017","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5301\/tj.5000696","article-title":"EURO-B.O.S.S.: a European study on chemotherapy in bone-sarcoma patients aged over 40: outcome in primary high-grade osteosarcoma","volume":"104","author":"Ferrari","year":"2018","journal-title":"Tumori"},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/0190-9622(91)70199-C","article-title":"The pharmacology of methotrexate","volume":"25","author":"Olsen","year":"1991","journal-title":"J Am Acad Dermatol."},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0950-3536(05)80282-3","article-title":"Methotrexate and leucovorin in malignant blood diseases","volume":"4","author":"Jolivet","year":"1991","journal-title":"Bailli\u00e8res Clin Haematol."},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1590\/2175-8239-jbn-2018-0095","article-title":"Successful multiple-exchange peritoneal dialysis in a patient with severe hematological toxicity by methotrexate: case report and literature review","volume":"41","author":"Aristizabal-Alzate","year":"2019","journal-title":"J Bras Nefrol"},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1634\/theoncologist.11-6-694","article-title":"Understanding and managing methotrexate nephrotoxicity","volume":"11","author":"Widemann","year":"2006","journal-title":"Oncologist"},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1200\/JCO.2009.25.4540","article-title":"Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome","volume":"28","author":"Widemann","year":"2010","journal-title":"J Clin Oncol."},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00467-002-0946-7","article-title":"Effective removal of methotrexate by high-flux hemodialysis","volume":"17","author":"Saland","year":"2002","journal-title":"Pediatr Nephrol."},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/104345429901600403","article-title":"Venipuncture versus central venous access: a comparison of methotrexate levels in pediatric leukemia patients","volume":"16","author":"Cash","year":"1999","journal-title":"J Pediatr Oncol Nurs."},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/0148607198022004234","article-title":"Central venous catheters versus peripheral veins for sampling blood levels of commonly used drugs","volume":"22","author":"Shulman","year":"1998","journal-title":"JPEN J Parenter Enteral Nutr."},{"key":"R12-20250603","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00007691-200306000-00002","article-title":"Sorption of thiotepa to polyurethane catheter causes falsely elevated plasma levels","volume":"25","author":"de Jonge","year":"2003","journal-title":"Ther Drug Monit."},{"key":"R13-20250603","first-page":"200","article-title":"Antibiotic sampling from central venous catheters versus peripheral veins","volume":"30","author":"McBeth","year":"2004","journal-title":"Pediatr Nurs."},{"journal-title":"Clin Biochem.","article-title":"Evaluation of serum and rapid serum separator collection tubes for therapeutic drug assays","author":"Garza","key":"R14-20250603"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001080","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:07:25Z","timestamp":1748970445000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001080","relation":{},"ISSN":["0163-4356"],"issn-type":[{"type":"print","value":"0163-4356"}],"subject":[],"published":{"date-parts":[[2023,2,28]]},"assertion":[{"value":"2022-08-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}